John Wilkerson is a Washington correspondent at RamaOnHealthcare. He focuses on the intersection of health and wellness, healthcare technology, and pharmaceuticals, covering topics such as pharmaceutical manufacturing, public health, and healthcare administration. His insights and analyses have been featured in STAT News and Daily Republic.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
John Wilkerson’s coverage predominantly focuses on healthcare and pharmaceuticals, with a strong emphasis on government announcements and legal policy regulations. Given this focus, he would likely be interested in receiving pitches from experts who can provide insights into the implications of new policies or regulatory changes within the healthcare and pharmaceutical sectors.
Given his interest in specific government actions related to drug pricing, FDA decisions, Medicare policies, and drug shortages, professionals with expertise in these areas may find success reaching out for commentary or analysis.
Wilkerson's US-based focus should be considered when pitching relevant stories or expert opinions tied to developments within the American healthcare system.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: John Wilkerson
New laws, more regulation of Chinese biopharma under consideration
Bill adds to challenges confronting hospitals amid efforts to control health care costs
By: John Wilkerson
Drugmakers offered GLP-1 discounts in exchange for more volume. They mostly got volume
You're reading the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.
By: John Wilkerson
Clinical trial diversity has gotten caught up in the Trump administration's attack on DEI
By: John Wilkerson
Clinical trial diversity has gotten caught up in the Trump administration's attack on DEI
You're reading the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.
You're reading the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.
I'm only just learning about the Norse soccer god Erling Haaland, who lives on copious amounts of organ meat and raw milk.
ARPA-H launches bespoke gene therapy push, Lilly and Novo to promote Bridge program, and more biotech news from The Readout
